Re Engage Therapeutics announced it raised $365,000 in an amended filing from an offering of $8 Million

Jul 01, 2025•21 days ago

Amount Raised

$365,000

Round Type

seed

HoustonHealth Care

Company Information

Company

ReEngage Therapeutics

Location

2450 HOLCOMBE BLVD. SUITE 1200

Houston, Texas, United States

About

ReEngage is a biopharmaceutical R&D company focused on developing drugs that treat longevity-related diseases. ReEngage does this by modifying epigenetic targets that are implicated in aging-related disorders, including neurodegeneration and cancer.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Re Engage Therapeutics announced it raised $365,000 in an amended filing from an offering of $8 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information